Optimizing chemotherapy and targeted agent combinations in NSCLC
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference37 articles.
1. Randomized, multinational, phase 211 study of docetaxeL plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 Study Group;Fossella;J Clin Oncol,2003
2. Randomized phase 211 trial of paclitaxeL plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group Trial;Kelly;J Clin Oncol,2001
3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002
4. Phase 211 randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer;Scagliotti;J Clin Oncol,2002
5. Randomized phase 2I/III trial of paclitaxeL (P) plus carboplatin (C) with or without bevacizumab (NSC# 704865) in patients with advanced non-squamous, non-small-cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial E4599;Sandler;J Clin Oncol,2005
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer;Frontiers in Oncology;2021-06-15
2. The ensemble of genetic factors and angiogenic signals via VEGF receptors in lung cancer progression;Cancer Biomarkers;2015-08-31
3. Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment;Lung Cancer;2014-02
4. Integration of EGFR Inhibitors and Conventional Chemotherapy in the Treatment of Non–Small-cell Lung Cancer;Clinical Lung Cancer;2011-11
5. Defining genome maintenance pathways using functional genomic approaches;Critical Reviews in Biochemistry and Molecular Biology;2011-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3